genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2009
Enzyme replacement therapy
News
Shire’s Enzyme Replacement Therapy for Gaucher’s Continues to Succeed in Late-Stage Studies
Insights
Companies Step In to Fill Gap in Enzyme Replacement Therapy for Gaucher’s
News
Shire’s Gaucher Disease Drug Candidate Being Considered by FDA
News
Alnara Gains Rights to Late-Stage Pancreatic Treatment from the Cystic Fibrosis Foundation
News
Shire Pays Zymenex $135M for CNS Disease Drug Candidate
News
Laureate to Manufacture Enobia Pharma’s Candidate against Hypophosphatasia
News
Altus Pharmaceuticals Hires Commercial Manufacturer
1
2
3
4
Page 4 of 4
Scroll Up
Scroll Up
